Illinois is currently home to 2661 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Chicago, Peoria, Springfield and Urbana. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
(VIII): The Eight Study and Immunologic Response Sub-study
Recruiting
The study's objective is to test the hypothesis that immune system activation and subsequent systemic inflammation can be detected through continuously tracking multiple bio signals including physiologic variables (ECG, skin temperature and their derivatives) and behavioral variables (activity and sleep from accelerometers) collected during routine activities of daily living using wearable biosensors. In the sub-study, the objective is to explore the association between these objectively measure... Read More
Gender:
All
Ages:
All
Trial Updated:
02/02/2022
Locations: physIQ, Chicago, Illinois
Conditions: Vaccine Reaction
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
Recruiting
This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/31/2022
Locations: Coronavirus Research Institute- Testing Site, Chicago, Illinois
Conditions: Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2
Impact of Sensor Technology in Knee OA
Recruiting
OBJECTIVES: Physical activity has been established as an important component of rehabilitation for knee osteoarthritis (OA), and is often guided by a physical therapist.(1) Physical therapy for knee OA typically involves 1-3 sessions with a licensed physical therapist per week, for up to 12 weeks. These sessions can take a lot of time and effort for subjects, particularly when travel times are considered. Remote patient monitoring is an emerging treatment method which can help to reduce the nee... Read More
Gender:
All
Ages:
Between 40 years and 75 years
Trial Updated:
01/24/2022
Locations: Shirley Ryan AbilityLab, Chicago, Illinois
Conditions: Knee Osteoarthritis
Safety and Effectiveness of the PXL-Platinum 330 System
Recruiting
To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.
Gender:
All
Ages:
8 years and above
Trial Updated:
01/24/2022
Locations: Chicago Cornea Consultants, Ltd., Highland Park, Illinois
Conditions: Corneal Ectasia, Keratoconus, Pellucid Marginal Corneal Degeneration
162 mg of Aspirin for Prevention of Preeclampsia
Recruiting
This is a study to assess if 162 mg of aspirin will decrease rates of preeclampsia in pregnant patients compared to 81 mg of aspirin.
Gender:
Female
Ages:
All
Trial Updated:
01/22/2022
Locations: UnityPoint Clinic Family Medicine, Peoria, Illinois
Conditions: Preeclampsia
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
Recruiting
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.
Gender:
All
Ages:
Between 18 years and 130 years
Trial Updated:
01/14/2022
Locations: Research Site, Chicago, Illinois
Conditions: Chronic Lymphocytic Leukemia
The EMPOWER Study: Endometriosis Diagnosis Using microRNA
Recruiting
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visi... Read More
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
01/11/2022
Locations: Northwestern Medicine, Chicago, Illinois
Conditions: Endometriosis
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Recruiting
This is a multicenter, open-label study conducted in two phases: Phase 1 consisting of a CGX1321 Single Agent Dose Escalation Phase in solid tumors, CGX1321 Single Agent Dose Expansion Phase in GI tumors and Roll-over Cohort of CGX1321 and pembrolizumab in subjects who have progressed on single agent CGX1321 and Phase 1b consisting of CGX1321 in combination with pembrolizumab in colorectal tumors and CGX1321 in combination with encorafenib + cetuximab in BRAFV600E mutated colorectal tumors. Both... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/11/2022
Locations: Edward H. Kaplan MD and Associates, Skokie, Illinois
Conditions: Solid Tumors, GI Cancer
Safety and Durability of Sirolimus for Treatment of LAM
Recruiting
The MIDAS study aims to follow LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR inhibitors (sirolimus or everolimus) as part of their clinical care. Adult female TSC patients may also enroll, with or without lung cysts.
Gender:
Female
Ages:
18 years and above
Trial Updated:
01/11/2022
Locations: Loyola University Medical Center, Chicago, Maywood, Illinois
Conditions: Lymphangioleiomyomatosis
A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
Recruiting
The purpose of this study is to determine the feasibility of producing artificial vision in persons with blindness. Study participants will have wireless electrical stimulators implanted into the cortical vision processing areas of their brains. The ability of the participants to perceive artificial vision in response to electrical stimulation will be assessed.
Gender:
All
Ages:
Between 19 years and 70 years
Trial Updated:
01/09/2022
Locations: Illinois Institue of Technology, Chicago, Illinois
Conditions: Ocular Injury, Optic Nerve Diseases, Photoreceptor Degeneration, Blindness,Acquired
The Cascade Feasibility Pilot (Ileostomy)
Recruiting
Existing interventions including improving communication and self-care to improve readmission of patients undergoing high risk colorectal surgery involving new ileostomy formation has shown limited results. Our proposal is to deploy a wearable solution that predicts physiological perturbation with continuous remote patient monitoring and advanced machine learning algorithms which will be connected to structured, cascading, escalation pathways and care coordination involving home health nurses, c... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
12/09/2021
Locations: NorthShore University HealthSystem Evanston Hospital, Evanston, Illinois
Conditions: Ileostomy; Complications, Ileostomy - Stoma
Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Recruiting
Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, enhanced patient education and informed consent, and potentially even modification of certain modifiable risk factors. The aim of the Prediction of adverse events after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to develop and externally validate a clinically app... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/05/2021
Locations: University of Illinois, Chicago, Illinois
Conditions: Aneurysm, Brain